Delayed
Hong Kong S.E.
01:31:25 2024-06-05 am EDT
|
5-day change
|
1st Jan Change
|
64.4
HKD
|
-0.39%
|
|
+2.29%
|
+14.68%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
34,207
|
18,333
|
8,691
|
10,138
|
-
|
-
|
Enterprise Value (EV)
2 |
30,611
|
14,683
|
6,002
|
7,417
|
6,906
|
6,809
|
P/E ratio
|
113
x
|
84.1
x
|
163
x
|
137
x
|
59.9
x
|
37.4
x
|
Yield
|
0.49%
|
0.55%
|
1.95%
|
1.31%
|
1.51%
|
1.17%
|
Capitalization / Revenue
|
26.9
x
|
14.4
x
|
5.89
x
|
5.83
x
|
4.76
x
|
3.87
x
|
EV / Revenue
|
24.1
x
|
11.6
x
|
4.07
x
|
4.27
x
|
3.24
x
|
2.6
x
|
EV / EBITDA
|
78.3
x
|
53.1
x
|
102
x
|
56.8
x
|
30.1
x
|
18.7
x
|
EV / FCF
|
124
x
|
257
x
|
88.4
x
|
74.8
x
|
44.3
x
|
27.1
x
|
FCF Yield
|
0.8%
|
0.39%
|
1.13%
|
1.34%
|
2.26%
|
3.69%
|
Price to Book
|
10.3
x
|
5
x
|
2.64
x
|
2.86
x
|
2.74
x
|
2.58
x
|
Nbr of stocks (in thousands)
|
168,332
|
168,761
|
169,098
|
169,221
|
-
|
-
|
Reference price
3 |
249.4
|
123.0
|
56.55
|
64.65
|
64.65
|
64.65
|
Announcement Date
|
3/24/22
|
3/23/23
|
3/19/24
|
-
|
-
|
-
|
1HKD in Million2CNY in Million3HKD Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,272
|
1,270
|
1,476
|
1,738
|
2,131
|
2,620
|
EBITDA
1 |
-
|
391
|
276.4
|
58.72
|
130.5
|
229.4
|
364.9
|
EBIT
1 |
-
|
318.3
|
211.3
|
-26.96
|
51.93
|
176.2
|
254.3
|
Operating Margin
|
-
|
25.03%
|
16.64%
|
-1.83%
|
2.99%
|
8.27%
|
9.7%
|
Earnings before Tax (EBT)
1 |
-
|
332.1
|
251.7
|
61.15
|
85.37
|
207
|
341.3
|
Net income
1 |
150.7
|
285.8
|
213.8
|
53.48
|
71.88
|
164.3
|
262.1
|
Net margin
|
-
|
22.48%
|
16.84%
|
3.62%
|
4.14%
|
7.71%
|
10%
|
EPS
2 |
1.260
|
2.199
|
1.462
|
0.3477
|
0.4731
|
1.079
|
1.730
|
Free Cash Flow
1 |
-
|
246.2
|
57.09
|
67.9
|
99.2
|
156
|
251.1
|
FCF margin
|
-
|
19.36%
|
4.5%
|
4.6%
|
5.71%
|
7.32%
|
9.58%
|
FCF Conversion (EBITDA)
|
-
|
62.96%
|
20.66%
|
115.64%
|
76.01%
|
68.01%
|
68.82%
|
FCF Conversion (Net income)
|
-
|
86.12%
|
26.7%
|
126.98%
|
138.01%
|
94.94%
|
95.81%
|
Dividend per Share
2 |
-
|
1.220
|
0.6800
|
1.100
|
0.8473
|
0.9773
|
0.7560
|
Announcement Date
|
6/3/21
|
3/24/22
|
3/23/23
|
3/19/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
571
|
700.6
|
570.9
|
698.8
|
616.3
|
859.6
|
742.1
|
1,006
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
117.5
|
200.8
|
72.69
|
138.6
|
-16.34
|
-10.62
|
13.57
|
3.348
|
Operating Margin
|
20.58%
|
28.66%
|
12.73%
|
19.84%
|
-2.65%
|
-1.24%
|
1.83%
|
0.33%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
25.58
|
-
|
-
|
Net income
|
-
|
189.7
|
74.31
|
139.5
|
-
|
21.17
|
-
|
-
|
Net margin
|
-
|
27.07%
|
13.01%
|
19.96%
|
-
|
2.46%
|
-
|
-
|
EPS
2 |
-
|
1.413
|
0.5040
|
0.9555
|
0.2048
|
0.1413
|
0.3150
|
0.2280
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/26/21
|
3/24/22
|
8/25/22
|
3/23/23
|
8/24/23
|
3/19/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
3,597
|
3,649
|
2,690
|
2,721
|
3,232
|
3,329
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
246
|
57.1
|
67.9
|
99.2
|
156
|
251
|
ROE (net income / shareholders' equity)
|
-
|
18.2%
|
6.73%
|
5.29%
|
2.08%
|
4.63%
|
7.43%
|
ROA (Net income/ Total Assets)
|
-
|
13%
|
5.4%
|
3.98%
|
1.44%
|
2.85%
|
4.34%
|
Assets
1 |
-
|
2,201
|
3,957
|
1,345
|
5,009
|
5,756
|
6,036
|
Book Value Per Share
2 |
-
|
24.20
|
24.60
|
21.40
|
22.60
|
23.60
|
25.10
|
Cash Flow per Share
2 |
-
|
3.400
|
1.000
|
1.060
|
2.150
|
2.160
|
1.780
|
Capex
1 |
-
|
196
|
89.8
|
98
|
122
|
130
|
141
|
Capex / Sales
|
-
|
15.38%
|
7.07%
|
6.64%
|
7.03%
|
6.12%
|
5.38%
|
Announcement Date
|
6/3/21
|
3/24/22
|
3/23/23
|
3/19/24
|
-
|
-
|
-
|
Last Close Price
64.65
HKD Average target price
84.59
HKD Spread / Average Target +30.84% Consensus |
1st Jan change
|
Capi.
|
---|
| +14.68% | 1.4B | | -14.75% | 20.72B | | +4.15% | 19.15B | | +9.49% | 13.94B | | +10.14% | 10.35B | | -15.21% | 2.12B | | +1.64% | 1.74B | | +9.07% | 547M | | 0.00% | 400M | | +55.29% | 179M |
Medical Prosthetics
|